- Barbara Duncan, Intercept Pharma's (NASDAQ:ICPT) CFO since 2009, is stepping down. Sandip Kapadia, CFO of Novartis' Sandoz generic drug unit, will succeed her, effective July 1.
- CEO Mark Pruzanski: "Sandip has substantial international financial management experience in the pharmaceutical industry and I look forward to working closely with him as we expand our commercial presence across the world, while advancing our global development programs."
Intercept Pharma announces CFO change
Recommended For You
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
ICPT | - | - |
Intercept Pharmaceuticals, Inc. |